Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Herpes simplex vaccine - Agenus

Next Previous
X
Search
Drug Profile

Herpes simplex vaccine - Agenus

Alternative Names: AG-707; HerpV; rhHSP70-PC

Latest Information Update: 02 Oct 2021

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Antigenics
  • Developer Agenus
  • Class Viral vaccines
  • Mechanism of Action CD4-positive T-lymphocyte stimulants; CD8 positive T lymphocyte stimulants; Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes - Herpes simplex virus infections

Highest Development Phases

  • Discontinued Herpes simplex virus type 2 infections

Most Recent Events

  • 16 Mar 2015 Agenus has patent protection for HerpV vaccine in USA
  • 01 Jan 2015 Agenus completes a phase II trial in Herpes simplex virus infections (recurrent, adjunctive therapy) in USA (SC)(NCT01687595)
  • 26 Jun 2014 HerpV is available for licensing (\http://www.agenusbio.com/\)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top